100 related articles for article (PubMed ID: 18372515)
1. Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour models.
Ghosh M; Bhattacharya S; Sadhu U; Dutta S; Sanyal U
Cancer Lett; 1997 Oct; 119(1):7-12. PubMed ID: 18372515
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
Sanyal U; Bhattacharya S; Sadhu U; Dutta S; Das H; Ghosh M
Cancer Lett; 1993 Jun; 70(1-2):1-6. PubMed ID: 8330289
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of toxicity of beta-tethymustine, a new anticancer compound, in mice.
Ghosh M; Sadhu U; Bhattacharya S; Dutta S; Bhattacharya B; Sanyal U
Cancer Lett; 1999 Apr; 138(1-2):107-14. PubMed ID: 10378781
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fluoren-NU as a novel antitumor agent.
Mukherjee A; Dutta S; Chashoo G; Bhagat M; Saxena AK; Sanyal U
Oncol Res; 2009; 17(9):387-96. PubMed ID: 19718945
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
10. Antitumour activity of saffron (Crocus sativus).
Nair SC; Pannikar B; Panikkar KR
Cancer Lett; 1991 May; 57(2):109-14. PubMed ID: 2025883
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
12. In vivo anti-tumour activity of novel Quinazoline derivatives.
Alapati V; Noolvi MN; Manjula SN; Pallavi KJ; Patel HM; Tippeswamy BS; Satyanarayana SV
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(13):1753-64. PubMed ID: 23208959
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
16. Acanthus ilicifolius plant extract prevents DNA alterations in a transplantable Ehrlich ascites carcinoma-bearing murine model.
Chakraborty T; Bhuniya D; Chatterjee M; Rahaman M; Singha D; Chatterjee BN; Datta S; Rana A; Samanta K; Srivastawa S; Maitra SK; Chatterjee M
World J Gastroenterol; 2007 Dec; 13(48):6538-48. PubMed ID: 18161924
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2014 Apr; 116():219-27. PubMed ID: 24486833
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model.
Ramachandran S; Mandal M
Biomed Pharmacother; 2011 Oct; 65(7):461-6. PubMed ID: 22000294
[TBL] [Abstract][Full Text] [Related]
19. Antitumour principles from Nigella sativa seeds.
Salomi NJ; Nair SC; Jayawardhanan KK; Varghese CD; Panikkar KR
Cancer Lett; 1992 Mar; 63(1):41-6. PubMed ID: 1555206
[TBL] [Abstract][Full Text] [Related]
20. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]